Three key factors increase the risk for patient-to-patient transmission of an extremely drug-resistant bacteria known as CP-CRE, according to a new study published today in Infection Control & Hospital Epidemiology. The research helps explain why some contacts of an infected patient acquire the dangerous bacteria while others do not.
"The spread of CP-CRE is a major public health concern because it is extremely drug resistant; however, the research on these pathogens is very limited, and so is our knowledge of their transmission," said Vered Schechner, MD, MSc, lead author of the study and an infection control physician in the department of epidemiology at Tel Aviv Sourasky Medical Center in Israel. "Identifying high-risk groups helps us to avoid excessive screening that can be risky and expensive, and to determine who should be screened and who might be a candidate for pre-emptive isolation or antibiotics."
CP-CRE, which stands for carbapenemase-producing carbapenem-resistant Enterobacteriacecae often affects patients in hospitals, nursing homes and other healthcare settings who require devices such as ventilators and catheters, and those who are taking long courses of certain antibiotics. Comparing infected patients with those showing no signs of CP-CRE, researchers found that 96 percent of patient-to-patient transmissions had at least one identified risk factor:
•Contact for more than three days with the infected individual;
•Mechanical ventilation; or
•Infection with another multidrug-resistant organism.
Additionally, researchers found that patients who had taken cephalosporins, a type of antibiotic, were less likely to acquire CP-CRE from another patient than those administered other antibiotics. Since antibiotic use is a risk factor for acquiring antibiotic-resistant organisms, it appears that cephalosporins might reduce the risk for CP-CRE compared to other drugs. However, there was no protective effect of cephalosporin when compared to patients receiving no antibiotics, and researchers said further study is needed.
The study was based on data from 3,158 adult inpatients who were screened for CP-CRE because of contact with another patient diagnosed with the pathogen between October 2008 and June 2012. In total, 53 patients were positive for CP-CRE and served as the case group, along with a group of 106 who had screened negative for CP-CRE.
Reference: Anat Schwartz-Neiderman, Tali Braun, Noga Fallach, David Schwartz, Yehuda Carmeli, Vered Schechner. "Risk factors for cabapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients." Web (July 25, 2016).
Source: Society for Healthcare Epidemiology of America (SHEA)
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.